Maria Trojano

Maria Trojano

UNVERIFIED PROFILE

Are you Maria Trojano?   Register this Author

Register author
Maria Trojano

Maria Trojano

Publications by authors named "Maria Trojano"

Are you Maria Trojano?   Register this Author

100Publications

2933Reads

32Profile Views

Autophagy markers LC3 and p62 accumulate in immune-mediated necrotizing myopathy.

Muscle Nerve 2019 Sep 21;60(3):315-327. Epub 2019 Jun 21.

Unit of Neurophysiopathology, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.26608DOI Listing
September 2019

Author Correction: Progress in multiple sclerosis - from diagnosis to therapy.

Nat Rev Neurol 2019 May;15(5):306

Department NEUROFARBA, Section Neurosciences, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41582-019-0179-zDOI Listing
May 2019

AQP4ex is crucial for the anchoring of AQP4 at the astrocyte end-feet and for neuromyelitis optica antibody binding.

Acta Neuropathol Commun 2019 Apr 1;7(1):51. Epub 2019 Apr 1.

Department of Basic Medical Sciences, Neurosciences and Sense Organs, School of Medicine, University of Bari Aldo Moro, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40478-019-0707-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444679PMC
April 2019

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.

Mult Scler 2019 04 20;25(4):591-600. Epub 2018 Mar 20.

Service de Neurologie A, Hôpital Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France/Observatoire Français de la Sclérose en Plaques (OFSEP), Lyon, France/Centre de Recherche en Neurosciences de Lyon, INSERM U1028, CNRS UMR5292, Equipe Neuro-Oncologie et Neuro-Inflammation, Lyon, France/Université de Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458518763080DOI Listing
April 2019

Investigating the Role of MicroRNA and Transcription Factor Co-regulatory Networks in Multiple Sclerosis Pathogenesis.

Int J Mol Sci 2018 Nov 20;19(11). Epub 2018 Nov 20.

National Research Council, Institute of Biomedical Technologies, Bari Unit, 70126 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms19113652DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274935PMC
November 2018

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.

Mult Scler 2018 10 31;24(12):1617-1626. Epub 2017 Aug 31.

Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia/Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/Department of Neurology, Box Hill Hospital, Monash University, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458517728812DOI Listing
October 2018

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy.

J Neurol Sci 2018 08 2;391:72-76. Epub 2018 Jun 2.

Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Neurology, Alfred Hospital, Melbourne, VIC, Australia; Box Hill Hospital, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2018.06.001DOI Listing
August 2018

Natalizumab reduces serum pro-angiogenic activity in MS patients.

Neurol Sci 2018 Apr 13;39(4):725-731. Epub 2018 Feb 13.

Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza G. Cesare 11, 70124, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10072-018-3266-9DOI Listing
April 2018

Complexity of MS management in the current treatment era.

Neurology 2018 04;90(17):761-762

From Partners Multiple Sclerosis Center (T.C.), Brigham and Women's Hospital, Boston, MA; Blizard Institute (G.G.), Barts and The London School of Medicine and Dentistry, Queen Mary University London, UK; and Department of Basic Medical Sciences, Neurosciences and Sense Organs (M.T.), University of Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005399DOI Listing
April 2018

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

Neurology 2018 03 7;90(10):e832-e839. Epub 2018 Feb 7.

From IRCCS Don Gnocchi Foundation (E.P.), Florence; Scientific Institute University Vita-Salute San Raffaele (L.M., V.M., G.C.), Milan; Multiple Sclerosis Study Center (P.A., A.G., M.Z.), ASST Valle Olona, Gallarate Hospital (VA); Department of Neurosciences, Reproductive and Odontostomatological Sciences (R.L., V.B.M.), Federico II University of Naples; Department of Neurosciences (F.R., P.G.), Multiple Sclerosis Centre-Veneto Region (CeSMuV), University Hospital of Padova; Department of Neurology (C.T., D.P., M.T.), University of Bari; Department of Neurology and Psychiatry (C.P., L.D.G.), "La Sapienza" University, Rome; Department of Neurology (P.C.), University of Torino; Department of Medical Sciences and Public Health (E.C., M.G.M.), University of Cagliari; Department of Neurology (C.S.), ASL3 Genovese; Department of Neurology (A.U., A.L.), University of Genova; and Department of NEUROFARBA (L.P., M.G., M.P.A.), University of Florence, Italy.

View Article

Download full-text PDF

Source
http://www.neurology.org/lookup/doi/10.1212/WNL.000000000000
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000005068DOI Listing
March 2018

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Neurology 2018 03 7;90(10):e823-e831. Epub 2018 Feb 7.

From IRCCS Don Gnocchi Foundation (E.P.), Florence; Multiple Sclerosis Study Center (P.A., A.G., M.Z.), ASST Valle Olona, Gallarate Hospital (VA); Scientific Institute University Vita-Salute San Raffaele (L.M., V.M., G.C.), Milan; Department of Neurosciences, Reproductive and Odontostomatological Sciences (R.L., V.B.M.), Federico II University of Naples; Department of Neurosciences (F.R., P.G.), Multiple Sclerosis Centre-Veneto Region (CeSMuV), University Hospital of Padova; Department of Neurology (C.T., D.P., M.T.), University of Bari; Department of Neurology and Psychiatry (C.P., L.D.G.), "La Sapienza" University, Rome; Department of Neurology (P.C.), University of Torino; Department of Medical Sciences and Public Health (E.C., M.G.M.), University of Cagliari; Department of Neurology (F.P.), University of Catania; Department of Neurology (C.S.), ASL3 Genovese; Multiple Sclerosis Center (P.B.), IRCCS Neuromed, Pozzilli; Department of Neurology (A.U., A.L.), University of Genova; and Department of NEUROFARBA (L.P., M.G., M.P.A.), University of Florence, Italy.

View Article

Download full-text PDF

Source
http://www.neurology.org/lookup/doi/10.1212/WNL.000000000000
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000005067DOI Listing
March 2018

Multiple sclerosis in 2017: Progress in multiple sclerosis - from diagnosis to therapy.

Nat Rev Neurol 2018 Jan;14(2):72-74

Department NEUROFARBA, Section Neurosciences, University of Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2018.3DOI Listing
January 2018

Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice.

Eur Neurol 2016 13;76(5-6):216-226. Epub 2016 Oct 13.

University of Lille, CHU Lille, LIRIC-INSERM U995, FHU Imminent, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000449413DOI Listing
September 2017

Treatment decisions in multiple sclerosis - insights from real-world observational studies.

Nat Rev Neurol 2017 Feb 13;13(2):105-118. Epub 2017 Jan 13.

Department of Medicine, University of Melbourne, and Department of Neurology, Royal Melbourne Hospital, Grattan Street, Parkville, VIC 3050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2016.188DOI Listing
February 2017

THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.

Authors:
Maria Trojano

Eur Neurol 2016 23;75 Suppl 1:4-8. Epub 2016 Feb 23.

Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000444235DOI Listing
October 2016

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.

J Neurol Neurosurg Psychiatry 2016 10 13;87(10):1133-7. Epub 2016 Jun 13.

Department of Neurology, Royal Melbourne Hospital, Parkville, Victoria, Australia Department of Medicine (RMH), The University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp-2016-313760DOI Listing
October 2016

Advances in the management of MS symptoms: real-life evidence.

Authors:
Maria Trojano

Neurodegener Dis Manag 2015 ;5(6 Suppl):19-21

Department of Basic Clinical Sciences, Neurosciences and Sense Organs, University of Bari, Italy, Policlinico di Bari, Piazza Giulio Cesare, 11 Zip-code 70124, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/nmt.15.66DOI Listing
September 2016

History of multiple sclerosis in 2 successive pregnancies: A French and Italian cohort.

Neurology 2016 Sep 27;87(13):1360-7. Epub 2016 Jul 27.

From the Service de Neurologie A (A.B., F.D.-D., S.R., G.A., L.G., I.I., R.M., C.C., S.V.), Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon/Bron; Centre des Neurosciences de Lyon (A.B., F.D.-D., S.R., G.A., L.G., I.I., R.M., C.C., S.V.), INSERM 1028 et CNRS UMR5292, Equipe Neuro-oncologie et Neuro-inflammation; Université de Lyon (A.B., F.D.-D., S.R., G.A., L.G., I.I., R.M., C.C., S.V.); Université Lyon 1 et Université de Lyon (A.B., R.C., S.R., R.M., C.C., S.V.), France; Department NEUROFARBA (M.-P.A., E.P.), Section Neurosciences, University of Florence, Italy; Observatoire Français de la Sclérose en Plaques (R.C., C.C., S.V.), Bron, France; Departments of Medical Sciences (M.-G.M.) and Public Health, Clinical and Molecular Medicine (E.C.), University of Cagliari; Hospital of Gallarate (A.G., P.A.), Varese; Department of Basic Medical Sciences (M.T., M.S.), Neurosciences and Sense Organs, University of Bari, Italy; Fondation Eugène Devic EDMUS contre la Sclérose en Plaques (R.M., C.C., S.V.), Bron; and Centre des Neurosciences de Lyon (R.M., C.C., S.V.), INSERM 1028 et CNRS UMR5292, Equipe Neuro-oncologie et Neuro-inflammation, France.

View Article

Download full-text PDF

Source
http://www.neurology.org/content/early/2016/07/27/WNL.000000
Web Search
http://dx.doi.org/10.1212/WNL.0000000000003036DOI Listing
September 2016

Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients.

J Neurol 2016 Aug 3;263(8):1620-5. Epub 2016 Jun 3.

Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza G. Cesare 11, 70124, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-016-8177-1DOI Listing
August 2016

The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?

Mult Scler 2016 08;22(2 Suppl):18-33

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516650739DOI Listing
August 2016

Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study.

Eur Neurol 2015 17;74(3-4):178-85. Epub 2015 Nov 17.

Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000441619DOI Listing
July 2016

Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.

J Clin Pharmacol 2016 07 30;56(7):845-51. Epub 2015 Dec 30.

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari "Aldo Moro,", Bari, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jcph.670
Publisher Site
http://dx.doi.org/10.1002/jcph.670DOI Listing
July 2016

Assessing response to interferon-β in a multicenter dataset of patients with MS.

Neurology 2016 Jul 15;87(2):134-40. Epub 2016 Jun 15.

From the University of Genoa (M.P.S.); Hospital San Camillo Forlanini (C.G.) and Department of Neurology and Psychiatry (L.P., C.P.), Sapienza University, Rome; Department of Neurology (M.R., V.M., G.C.) and Neuroimaging Research Unit (M.A.R., M.F.), San Raffaele Scientific Institute, Milan, Italy; Hospital Universitario Vall d'Hebron (J.R., M. Tintorè, A.R., X.M.), Barcelona, Spain; University of Verona (M.C.); Department of Public Health, Clinical and Molecular Medicine (E.C.), and Department of Medical Sciences (M.G.M., E.C.), University of Cagliari, Italy; Department of Neurology (C.E., F.F.), Medical University of Graz, Austria; Dip. to di Scienze Mediche, Chirurgiche, Neurologiche, Metaboliche e dell'Invecchiamento (A.G., G.T.), Seconda Universita' di Napoli, MRI Research Center "SUN-FISM," Hermitage-Capodimonte Clinic, Naples, Italy; Neurology (L.K., T.S.), Departments of Medicine, Clinical Research, and Biomedical Engineering, University Hospital Basel, Switzerland; DKD Helios Klinik Wiesbaden (T.S.), Germany; University of Siena (M.L.S., N.D.S.); and Department of Medical Sciences, Neurosciences and Sense Organs (M. Trojano, C.T.), University of Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000002830DOI Listing
July 2016

Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection.

PLoS One 2015 24;10(11):e0143679. Epub 2015 Nov 24.

Department of Bioscience, Biotechnologies and Biopharmaceutics and Center of Excellence in Comparative Genomics, University of Bari "Aldo Moro", 70126, Bari, Italy.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0143679PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658006PMC
June 2016

Recommendations for observational studies of comorbidity in multiple sclerosis.

Neurology 2016 Apr 10;86(15):1446-1453. Epub 2016 Feb 10.

From the Departments of Internal Medicine (R.A.M., K.F.) and Community Health Sciences (R.A.M., N.R.), University of Manitoba, Winnipeg, Canada; Icahn School of Medicine at Mount Sinai (A.M.), New York, NY; Biostatistic Unit, Department of Health Sciences (M.P.S.), University of Genova, Italy; Faculty of Brain Sciences (A.T.), University College London, UK; University of California San Francisco (E.W.); Department of Basic Medical Sciences, Neurosciences and Sense Organs (M.T.), University of Bari, Italy; St. Michael's Hospital (P.O.), Toronto, Canada; Scientific and Clinical Review Associates, LLC (S.R.), Salisbury, CT; and Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH.

View Article

Download full-text PDF

Source
http://www.neurology.org/content/early/2016/02/10/WNL.000000
Web Search
http://www.neurology.org/content/early/2016/02/10/WNL.000000
Web Search
http://www.neurology.org/cgi/doi/10.1212/WNL.000000000000247
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000002474DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831039PMC
April 2016

The challenge of comorbidity in clinical trials for multiple sclerosis.

Neurology 2016 Apr 17;86(15):1437-1445. Epub 2016 Feb 17.

From the Departments of Internal Medicine (R.A.M.) and Community Health Sciences (R.A.M.), University of Manitoba, Winnipeg, Canada; Icahn School of Medicine at Mount Sinai (A.M.), New York, NY; Biostatistic Unit (M.P.S.), Department of Health Sciences, University of Genova, Italy; Faculty of Brain Sciences (A.T.), University College London, UK; University of California San Francisco (E.W.); Department of Basic Medical Sciences, Neurosciences and Sense Organs (M.T.), University of Bari, Italy; St. Michael's Hospital (P.O.), Toronto, Canada; Scientific and Clinical Review Associates, LLC (S.R.), Salisbury, CT; and Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH.

View Article

Download full-text PDF

Source
http://www.neurology.org/content/early/2016/02/17/WNL.000000
Web Search
http://www.neurology.org/lookup/doi/10.1212/WNL.000000000000
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000002471DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831041PMC
April 2016

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.

Neurol Clin Pract 2016 Apr;6(2):102-115

Department of Medicine and Melbourne Brain Centre at the Royal Melbourne Hospital (TS, TK, VJ, HB), University of Melbourne, Australia; Biogen Idec Inc. (AZ, FP, SB, RH), Cambridge, MA; Department of Neurology (HW), University of Münster, Germany; Groene Hart Ziekenhuis (FV), Gouda, the Netherlands; MS Center, Department of Neuroscience, Imaging and Clinical Sciences (AL), University "G. d'Annunzio," Chieti, Italy; MS Center, Department of Neurology, First Medical Faculty (EH, DH), Charles University, Prague, Czech Republic; Center de Réadaptation Déficience Physique Chaudière-Appalache (PG), Levis; Hôpital Notre Dame (PD, AP), Montreal, Canada; Ospedali Riuniti di Salerno (G. Iuliano), Salerno, Italy; 19 Mayis University (M. Terzi), Medical Faculty, Turkey; Hospital Universitario Virgen Macarena (G. Izquierdo), Sevilla, Spain; Orbis Medical Centre (RMMH), Sittard-Geleen, the Netherlands; KTU Medical Faculty Farabi Hospital (CB), Trabzon, Turkey; Neurology Unit (EP, GG), ASUR Marche-AV3, Macerata; Nuovo Ospedale Civile S. Agostino (PS), Modena; AORN San Giuseppe Moscati (DLAS), Avellino, Italy; John Hunter Hospital (JL-S), Newcastle, Australia; Neurological Institute IRCCS Mondino (RB), Pavia, Italy; Neuro Rive-Sud (F. Grand'Maison), Hôpital Charles LeMoyne, Quebec, Canada; University of Parma (F. Granella), Italy; Department of Neurology (LK), University Hospital Basel, Switzerland; Department of Basic Medical Sciences, Neuroscience and Sense Organs (M. Trojano), University of Bari, Italy; and Department of Neurology (HB), Eastern Health, Monash University, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/CPJ.0000000000000227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828679PMC
April 2016

First evidence of in vivo pro-angiogenic activity of cerebrospinal fluid samples from multiple sclerosis patients.

Clin Exp Med 2016 Feb 25;16(1):103-7. Epub 2014 Dec 25.

Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Policlinico - Piazza G. Cesare, 11, 70124, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10238-014-0334-1DOI Listing
February 2016

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.

J Neurol Neurosurg Psychiatry 2016 Feb 25;87(2):126-9. Epub 2015 Feb 25.

Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK Department of Neurology, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp-2014-309690DOI Listing
February 2016

Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study.

J Clin Pharmacol 2015 Oct 17;55(10):1131-6. Epub 2015 Jun 17.

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.

View Article

Download full-text PDF

Source
http://formsus.datasus.gov.br/novoimgarq/28121/4885005_31236
Web Search
http://doi.wiley.com/10.1002/jcph.519
Publisher Site
http://dx.doi.org/10.1002/jcph.519DOI Listing
October 2015

Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlights.

Eur Neurol 2014 26;72 Suppl 1:15-9. Epub 2014 Sep 26.

Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/367619
Publisher Site
http://dx.doi.org/10.1159/000367619DOI Listing
June 2015

Comparative efficacy of switching to natalizumab in active multiple sclerosis.

Ann Clin Transl Neurol 2015 Apr 27;2(4):373-87. Epub 2015 Feb 27.

Department of Medicine and Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne Melbourne, Australia ; Department of Neurology, Eastern Health, Monash University Box Hill, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402083PMC
April 2015

A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis.

Mult Scler 2015 Mar 22;21(3):282-93. Epub 2014 Dec 22.

Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514564490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429166PMC
March 2015

A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis.

Mult Scler 2015 Mar 22;21(3):342-9. Epub 2014 Dec 22.

Department of Neurology and Neurotherapeutics, University of Texas Southwestern, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514564486DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429167PMC
March 2015

MS and related disorders: looking for markers of phenotypes.

Lancet Neurol 2015 Jan;14(1):11-3

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari 70124, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(14)70291-1DOI Listing
January 2015

Neuropsychological features in childhood and juvenile multiple sclerosis: five-year follow-up.

Neurology 2014 Oct 12;83(16):1432-8. Epub 2014 Sep 12.

From the Department of NEUROFARBA (M.P.A., B.G., B.H., C.N., S.L., E.P.), University of Florence; MS Centre (A.G., M.R.), Hospital of Gallarate; Neurological Department (L.M., M.F., V.M., G.C.), IRCCS Hospital San Raffaele, Milano; Department of Neuroscience and Sense Organs (R.G.V., M.T.), University of Bari; Multiple Sclerosis Centre (F.P., S.C.), University Polyclinic Hospital G. Rodolico, Catania; and Department of Neurological Sciences (C.P., V.B.), La Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000000885DOI Listing
October 2014

The use of multiple population-based data sources for estimating MS sex ratio trends over time.

Authors:
Maria Trojano

Mult Scler 2014 Oct;20(12):1551-2

Department of Basic Clinical Sciences, Neurosciences and Sense Organs, University of Bari, Italy, Policlinico di Bari, Piazza Giulio Cesare, 11 Zip-code 70124, Bari, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514536088DOI Listing
October 2014